| (S)-naringenin | multiple interactions | ISO | RGD:1346147 | 6480464 | fulvestrant inhibits the reaction [[naringenin binds to ESR1 protein] which results in increased activity of ALPL protein] | CTD | PMID:12650720 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1346147 | 6480464 | VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein] | CTD | PMID:12521655 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1346147 | 6480464 | fulvestrant inhibits the reaction [[Estradiol binds to ESR1 protein] which results in increased activity of ALPL protein] | CTD | PMID:12650720 |
| 17beta-estradiol | increases expression | ISO | RGD:731885 | 6480464 | Estradiol results in increased expression of ALPL mRNA | CTD | PMID:15289156 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1346147 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of ALPL mRNA | CTD | PMID:17404688 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | RGD:731885 | 6480464 | Dihydrotestosterone results in increased expression of ALPL mRNA | CTD | PMID:17898587 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1346147 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ALPL mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1346147 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ALPL protein | CTD | PMID:18724896 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:731885 | 6480464 | tributyltin promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of ALPL mRNA] | CTD | PMID:22749964 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:731885 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ALPL mRNA | CTD | PMID:22749964 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of ALPL protein]; more ... | CTD | PMID:11018766 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases activity | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased activity of ALPL protein | CTD | PMID:11018766 |
| 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein; more ... | CTD | PMID:15548946 |
| 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of ALPL protein]; more ... | CTD | PMID:15554553 |
| 2-amino-2-deoxy-D-glucopyranose | multiple interactions | ISO | RGD:1346147 | 6480464 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucosamine analog results in increased activity of ALPL protein] | CTD | PMID:20458730 |
| 2-amino-2-deoxy-D-glucopyranose | increases expression | ISO | RGD:1346147 | 6480464 | Glucosamine analog results in increased expression of ALPL mRNA | CTD | PMID:20458730 |
| 2-amino-2-deoxy-D-glucopyranose | increases activity | ISO | RGD:1346147 | 6480464 | Glucosamine analog results in increased activity of ALPL protein | CTD | PMID:20458730 |
| 2-butoxyethanol | decreases expression | ISO | RGD:731885 | 6480464 | n-butoxyethanol results in decreased expression of ALPL mRNA | CTD | PMID:19812364 |
| 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of ALPL protein | CTD | PMID:11289319 |
| 5-(2-methylpiperazine-1-sulfonyl)isoquinoline | decreases activity | EXP | | 6480464 | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine results in decreased activity of ALPL protein | CTD | PMID:11171635 |
| 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of ALPL mRNA | CTD | PMID:22504374 |
| aflatoxin B1 | affects expression | ISO | RGD:1346147 | 6480464 | Aflatoxin B1 affects the expression of ALPL protein | CTD | PMID:20106945 |
| aldehydo-D-glucosamine | multiple interactions | ISO | RGD:1346147 | 6480464 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucosamine analog results in increased activity of ALPL protein] | CTD | PMID:20458730 |
| aldehydo-D-glucosamine | increases expression | ISO | RGD:1346147 | 6480464 | Glucosamine analog results in increased expression of ALPL mRNA | CTD | PMID:20458730 |
| aldehydo-D-glucosamine | increases activity | ISO | RGD:1346147 | 6480464 | Glucosamine analog results in increased activity of ALPL protein | CTD | PMID:20458730 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1346147 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]]; more ... | CTD | PMID:10567916 |
| all-trans-retinoic acid | increases activity | EXP | | 6480464 | Tretinoin results in increased activity of ALPL protein | CTD | PMID:10567916 PMID:11171635 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1346147 | 6480464 | Tretinoin results in decreased expression of ALPL mRNA | CTD | PMID:21934132 |
| all-trans-retinoic acid | increases activity | EXP | | 6480464 | Tretinoin results in increased activity of ALPL protein | CTD | PMID:11171635 PMID:10567916 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ALPL mRNA | CTD | PMID:10567916 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]]; more ... | CTD | PMID:10567916 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | EGF protein inhibits the reaction [Tretinoin results in increased activity of ALPL protein]; more ... | CTD | PMID:11171635 |
| all-trans-retinoic acid | increases expression | ISO | RGD:731885 | 6480464 | Tretinoin results in increased expression of ALPL mRNA | CTD | PMID:16604517 |
| all-trans-retinoic acid | increases activity | ISO | RGD:731885 | 6480464 | Tretinoin results in increased activity of ALPL protein | CTD | PMID:10567916 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:731885 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]]; more ... | CTD | PMID:10567916 |
| all-trans-retinoic acid | increases activity | ISO | RGD:1346147 | 6480464 | Tretinoin results in increased activity of ALPL protein | CTD | PMID:10567916 |
| aluminium oxide | increases expression | ISO | RGD:1346147 | 6480464 | Aluminum Oxide results in increased expression of ALPL mRNA | CTD | PMID:19464052 |
| aluminium trichloride | decreases expression | EXP | | 6480464 | aluminum chloride results in decreased expression of ALPL protein | CTD | PMID:23065425 |
| ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of ALPL mRNA | CTD | PMID:16483693 |
| benzo[a]pyrene | increases expression | ISO | RGD:731885 | 6480464 | Benzo(a)pyrene results in increased expression of ALPL mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | increases expression | ISO | RGD:731885 | 6480464 | Benzo(a)pyrene results in increased expression of ALPL mRNA | CTD | PMID:21567390 PMID:21569818 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:731885 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of ALPL mRNA | CTD | PMID:21715664 |
| beta-D-glucosamine | multiple interactions | ISO | RGD:1346147 | 6480464 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide inhibits the reaction [Glucosamine analog results in increased activity of ALPL protein] | CTD | PMID:20458730 |
| beta-D-glucosamine | increases expression | ISO | RGD:1346147 | 6480464 | Glucosamine analog results in increased expression of ALPL mRNA | CTD | PMID:20458730 |
| beta-D-glucosamine | increases activity | ISO | RGD:1346147 | 6480464 | Glucosamine analog results in increased activity of ALPL protein | CTD | PMID:20458730 |
| bezafibrate | decreases activity | ISO | RGD:1346147 | 6480464 | Bezafibrate results in decreased activity of ALPL protein | CTD | PMID:8102192 |
| bezafibrate | increases expression | ISO | RGD:731885 | 6480464 | Bezafibrate results in increased expression of ALPL mRNA | CTD | PMID:21499286 |
| bezafibrate | multiple interactions | ISO | RGD:731885 | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [Bezafibrate results in increased expression of ALPL mRNA]; more ... | CTD | PMID:21499286 |
| bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of ALPL mRNA | CTD | PMID:22985736 |
| bisphenol A | multiple interactions | ISO | RGD:1346147 | 6480464 | [bisphenol A binds to ESR1 protein] which results in increased activity of ALPL protein | CTD | PMID:12650720 |
| bisphenol A | decreases expression | ISO | RGD:1346147 | 6480464 | bisphenol A results in decreased expression of ALPL mRNA | CTD | PMID:23146750 |
| cadmium atom | decreases expression | ISO | RGD:1346147 | 6480464 | Cadmium results in decreased expression of ALPL mRNA | CTD | PMID:20570719 |
| cadmium dichloride | decreases expression | ISO | RGD:1346147 | 6480464 | Cadmium Chloride results in decreased expression of ALPL mRNA | CTD | PMID:22019892 |
| cadmium dichloride | multiple interactions | ISO | RGD:1346147 | 6480464 | PD 98059 inhibits the reaction [Cadmium Chloride results in decreased expression of ALPL mRNA] | CTD | PMID:22019892 |
| calcium dihydroxide | increases expression | ISO | RGD:1346147 | 6480464 | Calcium Hydroxide results in increased expression of ALPL mRNA | CTD | PMID:22083529 |
| carbonyl sulfide | decreases expression | EXP | | 6480464 | carbonyl sulfide results in decreased expression of ALPL mRNA | CTD | PMID:19395590 |
| chloramphenicol | increases expression | ISO | RGD:1346147 | 6480464 | Chloramphenicol results in increased expression of ALPL mRNA | CTD | PMID:22083529 |
| chlorpyrifos | multiple interactions | ISO | RGD:731885 | 6480464 | Plant Extracts inhibits the reaction [[cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein] | CTD | PMID:15991261 |
| chromium atom | decreases activity | EXP | | 6480464 | Chromium results in decreased activity of ALPL protein | CTD | PMID:16866188 |
| clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ALPL mRNA | CTD | PMID:17602206 |
| cobalt dichloride | decreases expression | ISO | RGD:731885 | 6480464 | cobaltous chloride results in decreased expression of ALPL mRNA | CTD | PMID:16772336 |
| coumestrol | multiple interactions | ISO | RGD:1346147 | 6480464 | [Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein; more ... | CTD | PMID:12650720 |
| cyclosporin A | decreases expression | ISO | RGD:1346147 | 6480464 | Cyclosporine results in decreased expression of ALPL mRNA | CTD | PMID:20106945 |
| cypermethrin | multiple interactions | ISO | RGD:731885 | 6480464 | [cypermethrin co-treated with Chlorpyrifos] results in increased expression of ALPL protein; more ... | CTD | PMID:15991261 |
| cypermethrin | increases activity | EXP | | 6480464 | cypermethrin results in increased activity of ALPL protein | CTD | PMID:15365239 |
| daidzein | multiple interactions | ISO | RGD:1346147 | 6480464 | [daidzein binds to ESR1 protein] which results in increased activity of ALPL protein; more ... | CTD | PMID:12650720 |
| desferrioxamine B | decreases expression | ISO | RGD:731885 | 6480464 | Deferoxamine results in decreased expression of ALPL mRNA | CTD | PMID:16772336 |
| dexamethasone | multiple interactions | ISO | RGD:731885 | 6480464 | [Dexamethasone co-treated with 1,25-dihydroxyvitamin D] inhibits the reaction [WNT3A protein results in increased expression of ALPL protein] | CTD | PMID:15270777 |
| diethylstilbestrol | increases expression | ISO | RGD:731885 | 6480464 | Diethylstilbestrol results in increased expression of ALPL mRNA | CTD | PMID:15591538 PMID:15289156 |
| diethylstilbestrol | increases expression | ISO | RGD:731885 | 6480464 | Diethylstilbestrol results in increased expression of ALPL mRNA | CTD | PMID:15289156 PMID:15591538 |
| diuron | increases expression | EXP | | 6480464 | Diuron results in increased expression of ALPL mRNA | CTD | PMID:21551480 |
| eugenol | increases expression | ISO | RGD:1346147 | 6480464 | Eugenol results in increased expression of ALPL mRNA | CTD | PMID:22083529 |
| fenvalerate | multiple interactions | ISO | RGD:1346147 | 6480464 | fenvalerate inhibits the reaction [Progesterone results in increased activity of ALPL protein] | CTD | PMID:16326432 |
| fenvalerate | increases activity | EXP | | 6480464 | fenvalerate results in increased activity of ALPL protein | CTD | PMID:15696646 |
| formaldehyde | increases expression | ISO | RGD:1346147 | 6480464 | Formaldehyde results in increased expression of ALPL mRNA | CTD | PMID:22083529 |
| fulvestrant | multiple interactions | ISO | RGD:1346147 | 6480464 | fulvestrant inhibits the reaction [[Coumestrol binds to ESR1 protein] which results in increased activity of ALPL protein]; more ... | CTD | PMID:12650720 |
| gamma-aminobutyric acid | decreases abundance | ISO | RGD:731885 | 6480464 | ALPL gene mutant form results in decreased abundance of gamma-Aminobutyric Acid | CTD | PMID:7550313 |
| gamma-hexachlorocyclohexane | multiple interactions | EXP | | 6480464 | [Lindane co-treated with isoproturon] results in decreased activity of ALPL protein; more ... | CTD | PMID:11180283 |
| gamma-hexachlorocyclohexane | increases expression | EXP | | 6480464 | Lindane results in increased expression of ALPL protein | CTD | PMID:11180283 |
| gamma-hexachlorocyclohexane | increases activity | EXP | | 6480464 | Lindane results in increased activity of ALPL protein | CTD | PMID:11180283 |
| genistein | multiple interactions | ISO | RGD:1346147 | 6480464 | fulvestrant inhibits the reaction [[Genistein binds to ESR1 protein] which results in increased activity of ALPL protein] | CTD | PMID:12650720 |
| genistein | increases expression | ISO | RGD:731885 | 6480464 | Genistein results in increased expression of ALPL mRNA | CTD | PMID:15289156 |
| glycerol 2-phosphate | increases hydrolysis | ISO | RGD:1346147 | 6480464 | ALPL protein results in increased hydrolysis of beta-glycerophosphoric acid | CTD | PMID:18500657 |
| glycerol 2-phosphate | multiple interactions | ISO | RGD:731885 | 6480464 | [ALPL protein results in increased degradation of beta-glycerophosphoric acid] which results in increased abundance of Phosphates; more ... | CTD | PMID:17383965 |
| glycerol 2-phosphate | increases expression | ISO | RGD:1346147 | 6480464 | beta-glycerophosphoric acid results in increased expression of ALPL mRNA | CTD | PMID:18500657 |
| glycerol 2-phosphate | increases degradation | ISO | RGD:731885 | 6480464 | ALPL protein results in increased degradation of beta-glycerophosphoric acid | CTD | PMID:17383965 |
| glycerol 2-phosphate | increases activity | ISO | RGD:1346147 | 6480464 | beta-glycerophosphoric acid results in increased activity of ALPL protein | CTD | PMID:18500657 |
| glycerol 2-phosphate | multiple interactions | ISO | RGD:1346147 | 6480464 | [ALPL protein results in increased hydrolysis of beta-glycerophosphoric acid] which results in increased abundance of Phosphates; more ... | CTD | PMID:18500657 |
| glycyrrhetinate | multiple interactions | ISO | RGD:731885 | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased activity of ALPL protein]; more ... | CTD | PMID:21910061 |
| glycyrrhetinic acid | multiple interactions | ISO | RGD:731885 | 6480464 | 18alpha-glycyrrhetinic acid inhibits the reaction [BMP2 protein results in increased activity of ALPL protein]; more ... | CTD | PMID:21910061 |
| lead(0) | decreases expression | ISO | RGD:731885 | 6480464 | Lead results in decreased expression of ALPL mRNA | CTD | PMID:23086611 |
| levonorgestrel | multiple interactions | ISO | RGD:1346147 | 6480464 | VDR gene polymorphism affects the reaction [[Ethinyl Estradiol co-treated with Levonorgestrel] affects the expression of ALPL protein] | CTD | PMID:12521655 |
| melatonin | increases expression | ISO | RGD:1346147 | 6480464 | Melatonin results in increased expression of ALPL mRNA | CTD | PMID:20738756 |
| methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of ALPL mRNA | CTD | PMID:22504374 |
| N-methyl-N'-nitro-N-nitrosoguanidine | increases expression | ISO | RGD:1346147 | 6480464 | Methylnitronitrosoguanidine results in increased expression of ALPL mRNA | CTD | PMID:12634122 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [2-Acetylaminofluorene co-treated with Diethylnitrosamine] results in increased activity of ALPL protein; more ... | CTD | PMID:15548946 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of ALPL mRNA | CTD | PMID:17602206 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of ALPL mRNA | CTD | PMID:18164116 |
| N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | Allyl Compounds inhibits the reaction [[Diethylnitrosamine co-treated with 2-Acetylaminofluorene] results in decreased activity of ALPL protein]; more ... | CTD | PMID:15554553 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | ISO | RGD:731885 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] | CTD | PMID:10567916 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | EXP | | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] | CTD | PMID:10567916 |
| N-tosyl-L-phenylalanyl chloromethyl ketone | multiple interactions | ISO | RGD:1346147 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]] | CTD | PMID:10567916 |
| naphthalene | increases expression | ISO | RGD:731885 | 6480464 | naphthalene results in increased expression of ALPL mRNA | CTD | PMID:18978301 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of ALPL mRNA | CTD | PMID:19784758 |
| paracetamol | decreases expression | ISO | RGD:1346147 | 6480464 | Acetaminophen results in decreased expression of ALPL mRNA | CTD | PMID:21420995 |
| paracetamol | affects expression | ISO | RGD:731885 | 6480464 | Acetaminophen affects the expression of ALPL mRNA | CTD | PMID:17562736 |
| paricalcitol | multiple interactions | ISO | RGD:1346147 | 6480464 | [Phosphorus co-treated with paricalcitol] results in increased expression of ALPL mRNA | CTD | PMID:17715259 |
| perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of ALPL mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | increases expression | EXP | | 6480464 | perfluorooctanoic acid results in increased expression of ALPL mRNA | CTD | PMID:19162173 |
| perfluorooctanoic acid | decreases expression | ISO | RGD:1346147 | 6480464 | perfluorooctanoic acid results in decreased expression of ALPL mRNA | CTD | PMID:23146750 |
| permethrin | multiple interactions | ISO | RGD:1346147 | 6480464 | Permethrin inhibits the reaction [Progesterone results in increased activity of ALPL protein] | CTD | PMID:16326432 |
| phenobarbital | increases expression | ISO | RGD:731885 | 6480464 | Phenobarbital results in increased expression of ALPL mRNA | CTD | PMID:19482888 |
| phenobarbital | multiple interactions | ISO | RGD:731885 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ALPL mRNA] | CTD | PMID:19482888 |
| phenol | increases expression | ISO | RGD:1346147 | 6480464 | Phenol results in increased expression of ALPL mRNA | CTD | PMID:22083529 |
| phosphorus atom | multiple interactions | ISO | RGD:1346147 | 6480464 | [Phosphorus co-treated with paricalcitol] results in increased expression of ALPL mRNA | CTD | PMID:17715259 |
| phosphorus(.) | multiple interactions | ISO | RGD:1346147 | 6480464 | [Phosphorus co-treated with paricalcitol] results in increased expression of ALPL mRNA | CTD | PMID:17715259 |
| pirinixic acid | increases expression | ISO | RGD:731885 | 6480464 | pirinixic acid results in increased expression of ALPL protein | CTD | PMID:19176532 |
| pirinixic acid | increases expression | ISO | RGD:731885 | 6480464 | pirinixic acid results in increased expression of ALPL mRNA | CTD | PMID:20059764 PMID:20813756 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of ALPL mRNA | CTD | PMID:19162173 |
| pirinixic acid | multiple interactions | ISO | RGD:731885 | 6480464 | RXRA protein promotes the reaction [pirinixic acid results in increased expression of ALPL protein] | CTD | PMID:19176532 |
| pirinixic acid | multiple interactions | ISO | RGD:731885 | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of ALPL mRNA] | CTD | PMID:20059764 |
| pirinixic acid | increases expression | ISO | RGD:731885 | 6480464 | pirinixic acid results in increased expression of ALPL mRNA | CTD | PMID:20813756 PMID:20059764 |
| potassium dichromate | decreases activity | EXP | | 6480464 | Potassium Dichromate results in decreased activity of ALPL protein | CTD | PMID:16866188 |
| procaine | increases expression | ISO | RGD:1346147 | 6480464 | Procaine results in increased expression of ALPL mRNA | CTD | PMID:22083529 |
| progesterone | multiple interactions | ISO | RGD:1346147 | 6480464 | fenvalerate inhibits the reaction [Progesterone results in increased activity of ALPL protein]; more ... | CTD | PMID:16326432 |
| progesterone | increases expression | ISO | RGD:1346147 | 6480464 | Progesterone results in increased expression of ALPL mRNA | CTD | PMID:17404688 |
| progesterone | increases activity | ISO | RGD:1346147 | 6480464 | Progesterone results in increased activity of ALPL protein | CTD | PMID:16326432 |
| progesterone | multiple interactions | ISO | RGD:1346147 | 6480464 | [Progesterone co-treated with Estradiol] results in increased expression of ALPL mRNA | CTD | PMID:17404688 |
| pyridoxal 5'-phosphate | increases abundance | ISO | RGD:731885 | 6480464 | ALPL gene mutant form results in increased abundance of Pyridoxal Phosphate | CTD | PMID:7550313 |
| pyrogallol | increases expression | ISO | RGD:731885 | 6480464 | Pyrogallol results in increased expression of ALPL mRNA | CTD | PMID:20362636 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of ALPL protein]; more ... | CTD | PMID:11018766 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of ALPL mRNA | CTD | PMID:21515302 |
| rosiglitazone | decreases expression | ISO | RGD:731885 | 6480464 | rosiglitazone results in decreased expression of ALPL mRNA | CTD | PMID:23086663 PMID:23322813 |
| rosiglitazone | decreases expression | ISO | RGD:731885 | 6480464 | rosiglitazone results in decreased expression of ALPL mRNA | CTD | PMID:23086663 |
| simvastatin | increases expression | ISO | RGD:731885 | 6480464 | Simvastatin results in increased expression of ALPL mRNA | CTD | PMID:20417880 |
| tamoxifen | affects expression | ISO | RGD:731885 | 6480464 | Tamoxifen affects the expression of ALPL mRNA | CTD | PMID:20937368 |
| tetrachloromethane | decreases expression | ISO | RGD:731885 | 6480464 | Carbon Tetrachloride results in decreased expression of ALPL mRNA | CTD | PMID:17484886 |
| tetrachloromethane | increases activity | ISO | RGD:731885 | 6480464 | Carbon Tetrachloride results in increased activity of ALPL protein | CTD | PMID:18436364 |
| tetrachloromethane | multiple interactions | ISO | RGD:731885 | 6480464 | phenyl caffeate inhibits the reaction [Carbon Tetrachloride results in increased activity of ALPL protein] | CTD | PMID:18436364 |
| thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of ALPL mRNA | CTD | PMID:19784758 |
| titanium dioxide | increases expression | ISO | RGD:1346147 | 6480464 | titanium dioxide results in increased expression of ALPL mRNA | CTD | PMID:19464052 |
| titanium dioxide | increases expression | ISO | RGD:731885 | 6480464 | titanium dioxide results in increased expression of ALPL mRNA | CTD | PMID:21259345 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in decreased activity of ALPL protein]; more ... | CTD | PMID:11018766 |
| tributylstannane | decreases expression | ISO | RGD:731885 | 6480464 | tributyltin results in decreased expression of ALPL mRNA | CTD | PMID:22749964 |
| tributylstannane | decreases expression | ISO | RGD:731885 | 6480464 | tributyltin results in decreased expression of ALPL mRNA | CTD | PMID:22749964 PMID:23322813 |
| tributylstannane | multiple interactions | ISO | RGD:731885 | 6480464 | tributyltin promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of ALPL mRNA] | CTD | PMID:22749964 |
| trimellitic anhydride | increases expression | ISO | RGD:731885 | 6480464 | trimellitic anhydride results in increased expression of ALPL mRNA | CTD | PMID:19042947 |
| tunicamycin | multiple interactions | ISO | RGD:1346147 | 6480464 | Tosylphenylalanyl Chloromethyl Ketone inhibits the reaction [Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]]; more ... | CTD | PMID:10567916 |
| tunicamycin | multiple interactions | EXP | | 6480464 | Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]; more ... | CTD | PMID:10567916 |
| tunicamycin | multiple interactions | ISO | RGD:731885 | 6480464 | Tunicamycin inhibits the reaction [Tretinoin results in increased activity of ALPL protein]; more ... | CTD | PMID:10567916 |
| tunicamycin | increases degradation | ISO | RGD:1346147 | 6480464 | Tunicamycin results in increased degradation of ALPL protein | CTD | PMID:10567916 |
| valproic acid | affects expression | ISO | RGD:731885 | 6480464 | Valproic Acid affects the expression of ALPL mRNA | CTD | PMID:17292431 |
| vancomycin | increases expression | ISO | RGD:731885 | 6480464 | Vancomycin results in increased expression of ALPL mRNA | CTD | PMID:18930951 |
| zearalenone | multiple interactions | ISO | RGD:1346147 | 6480464 | fulvestrant inhibits the reaction [[Zearalenone binds to ESR1 protein] which results in increased activity of ALPL protein] | CTD | PMID:12650720 |
| zinc atom | increases expression | EXP | | 6480464 | Zinc results in increased expression of ALPL mRNA | CTD | PMID:16413754 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of ALPL mRNA | CTD | PMID:21893222 |
| zinc dichloride | multiple interactions | ISO | RGD:731885 | 6480464 | [zinc chloride deficiency co-treated with N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine] results in decreased expression of ALPL mRNA | CTD | PMID:19913120 |
| zinc(0) | increases expression | EXP | | 6480464 | Zinc results in increased expression of ALPL mRNA | CTD | PMID:16413754 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of ALPL mRNA | CTD | PMID:21893222 |
| zoledronic acid | multiple interactions | ISO | RGD:731885 | 6480464 | TNFRSF11B protein affects the reaction [zoledronic acid results in decreased activity of ALPL protein] | CTD | PMID:18496637 |
| zoledronic acid | decreases activity | ISO | RGD:731885 | 6480464 | zoledronic acid results in decreased activity of ALPL protein | CTD | PMID:18496637 |